Goldman Sachs’s AdaptHealth AHCO Stock Holding History

Goldman Sachs’s Portfolio AHCO Stock Details AHCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-70,000	Closed	-$637K	–	5600
2023 Q3	$637K	Buy	+70,000	New	+$839K	﹤0.01%	4527

Other funds holding AHCO

OCA

OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return

SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs's AHCO Position: Q1 2026 in Review

Goldman Sachs increased its AdaptHealth (AHCO) stake by 204% in Q1 2026, buying an estimated $7.76M and bringing the position to 1,129,645 shares worth $13.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2806.

Goldman Sachs first reported a position in AHCO in Q3 2019 and has held it in 26 quarters since. 241 funds tracked by Wall St. Rank hold AHCO as of Q1 2026.

Goldman Sachs held 1,129,645 shares of AdaptHealth worth $13.4M as of Q1 2026.
Goldman Sachs bought 757,864 AdaptHealth shares in Q1 2026, an estimated $7.76M.
AdaptHealth made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #2806 holding.
Goldman Sachs first reported a position in AdaptHealth in Q3 2019 and has held it in 26 quarters since.
241 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.